#glioblastoma

Our fear that something awful might happen can rob joy from the present moment, says Adam Hayden, who just received good news.

Researchers created a new type of cancer drug that causes lethal DNA damage in the cells of brain tumors called glioblastomas.

Researchers identified genetic alterations in gliomas, a common brain tumor, that may lead to better treatments.

“It’s my shmita year, a year to let go,” writes blogger Adam Hayden. “Curious? Confused? Intrigued? Smiling? Read on.”

You can’t live with brain cancer and stay safe, so let’s take risks.

Study is first to show benefit of any targeted drugs in glioblastomas—the most aggressive brain tumors.

Five years ago, two surgeons partnered to remove the majority of a 71mm primary brain tumor from my medial right parietal lobe.

Those on the margins of society or with life-limiting illnesses and other social determinants offer a wisdom that often goes unrecognized.

It is difficult, if not impossible, to imprint on others the what-it’s-likeness of cancer, in my case, brain cancer.

An oncolytic virus that kills cancer cells and triggers immune responses against tumors shows promise for children with brain cancer.

While battling glioblastoma, Eric Smith feared he wouldn’t get to see his daughter grow up. He’s had the chance thanks to a clinical trial.

An inside look at five research developments that have the potential to transform the treatment of cancer

Patients are told not to throw in the towel. But when we frame cancer survivorship by a relentless battle, we award the wrong priorities.

Cancer Health blogger Adam Hayden, 38, a philosopher and palliative care advocate, lives in Indianapolis with his wife and three sons.

Study finds that patients with glioblastoma who received corticosteroid dexamethasone had significantly worse overall survival.

Recently, we met (virtually) with my neuro-oncologist to hear the results of my recent MRI scan.